Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Monica Epstein"'
Autor:
Benjamin L. Green, Alisa N. Blumenthaler, Lauren A. Gamble, James D. McDonald, Kristen Robinson, Maureen Connolly, Monica Epstein, Jonathan M. Hernandez, Andrew M. Blakely, Brian D. Badgwell, Jeremy L. Davis
Publikováno v:
Annals of Surgical Oncology. 30:1852-1860
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0948f8d74dffc11e9b84c59ad771332b
https://doi.org/10.1245/s10434-022-12761-0
https://doi.org/10.1245/s10434-022-12761-0
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
A CONSORT diagram of patients on trials not previously reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06da035f308bb598100adf8e71c56769
https://doi.org/10.1158/1078-0432.22481738.v1
https://doi.org/10.1158/1078-0432.22481738.v1
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
Purpose:Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TIL) can mediate durable responses in patients with metastatic melanoma. This retrospective analysis provides long-term follow-up and describes the effect of prior the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f65b05eb847244026d1327c65c3d70
https://doi.org/10.1158/1078-0432.c.6530759
https://doi.org/10.1158/1078-0432.c.6530759
Autor:
Stephanie L. Goff, Steven A. Rosenberg, Donald E. White, David N. Danforth, Zulmarie Franco, Michelle M. Langhan, Thomas E. Shelton, Monica Epstein, Christine T. McGowan, Amy R. Copeland, Mackenzie L. Shindorf, Paul F. Robbins, James C. Yang, Richard M. Sherry, Samantha J. Seitter
Table S2 describes treatment characteristics by clinical response to treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6154f421dcba271477e13fdd4b2ee1
https://doi.org/10.1158/1078-0432.22481726
https://doi.org/10.1158/1078-0432.22481726
Autor:
Sara Silbert, Kristen Cole, Sima Z. Bedoya, Alexandra F. Freeman, Jennifer S. Whangbo, Daniele N. Avila, Helen C. Su, Bonnie Yates, Monica Epstein, David S. Wendler, Sung-Yun Pai, Dennis D. Hickstein, Lori Wiener, Nirali N. Shah
Publikováno v:
Bone Marrow Transplantation. 57:1721-1723
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1457eef942a8f0592fc0f61ec4283b3c
https://doi.org/10.1038/s41409-022-01778-4
https://doi.org/10.1038/s41409-022-01778-4
Autor:
Benjamin L. Green, Alisa N. Blumenthaler, Lauren A. Gamble, James D. McDonald, Kristen Robinson, Maureen Connolly, Monica Epstein, Jonathan M. Hernandez, Andrew M. Blakely, Brian D. Badgwell, Jeremy L. Davis
Publikováno v:
Annals of Surgical Oncology. 30:1861-1862
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e1180f1f43bd34dcb850f00a387519
https://doi.org/10.1245/s10434-022-12845-x
https://doi.org/10.1245/s10434-022-12845-x
Autor:
Irina Maric, Nisha Patel, Manisha Bhutani, Hao-Wei Wang, Mark Roschewski, Michael Emanuel, Constance M. Yuan, Esther Mena, Monica Epstein, Raul C. Braylan, Katherine R. Calvo, Dickran Kazandjian, Maryalice Stetler-Stevenson, Crystal Lu, Liza Lindenberg, Elizabeth M. Hill, Seth M. Steinberg, Candis Morrison, Alina Dulau-Florea, Elisabet E. Manasanch, Nishant Tageja, Peter L. Choyke, Mary L Kwok, Neha Korde, Ola Landgren, William D. Figg, Alexander Dew, Sham Mailankody, Yong Zhang, Ashley Carpenter
Publikováno v:
Blood. 136:43-45
Background: HR-SMM is a plasma cell disorder with a 5-year risk of progression to symptomatic multiple myeloma (MM) of ~75% without therapy. Early treatment with novel therapies, may decrease the risk of progression and prolong survival as evidenced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eda78f4f315f41244ca4bab14755a50
https://doi.org/10.1182/blood-2020-136148
https://doi.org/10.1182/blood-2020-136148
Autor:
Lori McIntyre, Yong-Chen Lu, Liqiang Xi, Richard A. Morgan, Steven A. Feldman, Stephanie L. Goff, Parisa Malekzadeh, Lily Lu, Howard A. Fine, Richard M. Sherry, Nicholas P. Restifo, Monica Epstein, Zhili Zheng, Paul F. Robbins, Mark Raffeld, James Chih-Hsin Yang, Steven A. Rosenberg
Publikováno v:
J Immunother
A deletion variant of epidermal growth factor receptor (EGFRvIII) is a known driver mutation in a subset of primary and secondary glioblastoma multiforme. Adoptive transfer of genetically modified chimeric-antigen receptor (CAR) lymphocytes has demon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f112e425cebd9699bf31134aa3e5de30
https://doi.org/10.1097/cji.0000000000000260
https://doi.org/10.1097/cji.0000000000000260
Autor:
Christine T. McGowan, Monica Epstein, Michelle M. Langhan, Paul F. Robbins, Stephanie L. Goff, Zulmarie Franco, Richard M. Sherry, Steven A. Rosenberg, David N. Danforth, James Chih-Hsin Yang, Samantha Seitter, Mackenzie L. Shindorf, Amy R. Copeland, Donald E. White, Thomas E. Shelton
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(19)
Purpose: Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TIL) can mediate durable responses in patients with metastatic melanoma. This retrospective analysis provides long-term follow-up and describes the effect of prior th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e48580b69f24b99440016de0251e861
https://pubmed.ncbi.nlm.nih.gov/34413160
https://pubmed.ncbi.nlm.nih.gov/34413160
Autor:
Candis Morrison, Elizabeth Gil Ramirez, Dickran Kazandjian, Elizabeth M. Hill, Monica Epstein, Michael Emanuel, Emily Bryer, Alexander Dew, Jennifer Jones, Kevin Camphausen, Ashley Carpenter
Publikováno v:
Blood. 136:10-11
Background: Multiple myeloma (MM) is the 2nd most common hematologic malignancy and remains incurable despite significant treatment advances over the last decade. Patients with relapsed/refractory multiple myeloma (RRMM), who have exhausted available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7578a80b4baa66aca0b3d09278ded349
https://doi.org/10.1182/blood-2020-136176
https://doi.org/10.1182/blood-2020-136176